Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasovist MRI for Congenital Heart Disease Diagnosis
NCT00668824Phase 4Unknown
- Sponsor
- Guy's Hospital
- Start
- Mar 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gadofosveset in congenital heart disease (CHD), sponsored by Guy's Hospital. Primary endpoints: Improvement of diagnosis of CHD, Image quality analysis and 1 more. Status: unknown.
02
Drugs
gadofosveset
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT00668824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668824.